Nafees Malik
Corporate Officer/Principal bij Juvenescence, Inc.
Profiel
Nafees N.
Malik was the founder of Asklepian Consulting Ltd.
founded in 2013, where he held the title of Managing Director.
Currently, he is the Head-Cell & Gene Therapy at Juvenescence, Inc. since 2018.
He was the Chief Operating Officer at AgeX Therapeutics, Inc. from 2018 to 2023.
Dr. Malik holds a doctorate degree from The University of Liverpool and a graduate degree from the University of Cambridge.
Actieve functies van Nafees Malik
| Bedrijven | Functie | Begin |
|---|---|---|
| Juvenescence, Inc. | Corporate Officer/Principal | 01-10-2018 |
Eerdere bekende functies van Nafees Malik
| Bedrijven | Functie | Einde |
|---|---|---|
| AGEX THERAPEUTICS, INC. | Chief Operating Officer | 27-12-2023 |
| Asklepian Consulting Ltd. | Chief Executive Officer | - |
Opleiding van Nafees Malik
| The University of Liverpool | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
| Juvenescence, Inc. | Miscellaneous |
| Asklepian Consulting Ltd. |
